Keywords

You will be asked to select up to five (5) keywords in order of importance that are broad and inclusive. Keywords aid in the review process, help tag presentations, and if applicable, determine placement of the abstract in a session. Keywords also help identify the themes of your abstract.

Group 1: A-F
  1. Alternative splicing
  2. Alzheimer’s disease
  3. Ancient DNA
  4. Aneuploidy
  5. Anxiety
  6. Artificial intelligence
  7. Asthma
  8. Ataxia
  9. Autism
  10. Autoimmune disorder
  11. Behavior
  12. Biochemical pathology
  13. Bioinformatics
  14. Bone marrow transplantation
  15. Bone/joint abnormalities
  16. Brain/nervous system
  17. Cancer
  18. Cancer cytogenetics
  19. Cancer syndromes
  20. Candidate gene
  21. Cardiovascular system
  22. Cell-free DNA
  23. Cellular metabolism
  24. Channelopathies
  25. Characterization of disorders
  26. Characterization of syndromes
  27. Chromatin
  28. Chromosomal abnormalities
  29. Chromosomal deletions
  30. Chromosomal structure/function
  31. Ciliopathies
  32. Clinical genetics
  33. Clinical history
  1. Clinical testing
  2. Complex diseases
  3. Complex traits
  4. Computational tools
  5. Consanguinity
  6. Copy number/structural variation
  7. COVID-19
  8. Databases
  9. Deep learning
  10. Delineation of diseases
  11. Depression
  12. Development
  13. Diabetes
  14. Diagnostics
  15. Differentiation
  16. Education
  17. Electronic health records (EHRs)
  18. Endocrine system
  19. Epidemiology
  20. Epigenetics
  21. Epigenome-wide association studies (EWAS)
  22. Epilepsy
  23. Ethical, legal, and social implications (ELSI)
  24. Etiology
  25. Evolution
  26. Evolutionary genetics
  27. Exome/genome sequencing
  28. Expression quantitative trait loci (eQTL)
  29. Family history
  30. FISH
Group 2: G-N
  1. Gastrointestinal system
  2. Gene environment interaction
  3. Gene families
  4. Gene regulation
  5. Gene therapy
  6. Genetic counseling
  7. Genetic diversity
  8. Genetic epidemiology
  9. Genetic instability
  10. Genetic mapping
  11. Genetic testing
  12. Genitourinary system
  13. Genome editing/CRISPR
  14. Genome sequencing
  15. Genome-wide association study (GWAS)
  16. Genomic structure
  17. Genomics
  18. Genotype-phenotype correlations
  19. Haplotype
  20. Hematopoietic system
  21. Heritability
  22. Identification of disease genes
  23. Immune system
  24. Infectious disease
  25. Infertility
  26. Inheritance patterns
  27. Intellectual and developmental disability
  28. Large-scale biobanks
  29. Linkage disequilibrium
  30. Long-read sequencing
  31. Lysosomal diseases
  1. Machine learning
  2. Malformation
  3. Massively parallel sequencing
  4. Maternal serum screening
  5. Mathematical modeling
  6. Mendelian disorder
  7. Mendelian randomization
  8. Metabolic disorder
  9. Metabolomics
  10. Methodology
  11. Methylation
  12. Microarrays
  13. Microbiome
  14. MicroRNA
  15. Mitochondria
  16. Model organisms
  17. Molecular cytogenetics
  18. Molecular pathophysiology
  19. Mosaicism
  20. Multi-omics
  21. Muscular abnormalities
  22. Mutation detection
  23. Natural history
  24. Natural selection
  25. Nervous system
  26. Neurodegeneration
  27. Neurodevelopmental
  28. Neurogenetics
  29. Newborn screening
  30. NIPT
  31. Non-coding RNA
Group 3: O-X
  1. Obesity
  2. Oncogenesis
  3. Pathogenesis
  4. Pharmacogenomics
  5. Pharmacologic therapy
  6. Phenome-wide association
  7. Phenotype
  8. Policy issues
  9. Polygenic risk score
  10. Polymorphism
  11. Population genetics
  12. Population structure
  13. Precision medicine
  14. Prenatal diagnosis
  15. Protein structure
  16. Proteomics
  17. Psychiatric genetics
  18. Psychosocial issues
  19. Public health
  20. Quantitative trait
  21. Rare variants
  22. Regulation of transcription
  23. Reproductive genetics
  24. Respiratory system
  25. Risk assessment
  26. RNA
  27. RNAi
  28. RNA-seq
  1. Sensory disorders
  2. Sequencing technology
  3. Single-cell
  4. Skeletal system
  5. SNP analysis/discovery
  6. Somatic variants
  7. Spatial transcriptomics
  8. Splicing mechanisms
  9. Statistical genetics
  10. Stem cell(s)
  11. Susceptibility locus
  12. Systems biology
  13. Targeted sequencing
  14. Teratogens
  15. Transcription
  16. Transcription factor
  17. Transcriptome
  18. Transgenic model
  19. Translational studies and preclinical trials
  20. Triplet and other repeats
  21. Variant calling
  22. Variant interpretation
  23. Visual systems
  24. Women’s health
  25. X-linked disease

Questions?

Contact ASHG

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy